SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-063347
Filing Date
2019-11-13
Accepted
2019-11-13 16:31:27
Documents
70
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-17617_110q.htm 10-Q 864205
2 EX-31.1 a19-17617_1ex31d1.htm EX-31.1 9689
3 EX-31.2 a19-17617_1ex31d2.htm EX-31.2 9665
4 EX-32.1 a19-17617_1ex32d1.htm EX-32.1 5903
5 EX-32.2 a19-17617_1ex32d2.htm EX-32.2 5912
  Complete submission text file 0001104659-19-063347.txt   4687262

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ards-20190930.xml EX-101.INS 880763
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ards-20190930.xsd EX-101.SCH 47540
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ards-20190930_cal.xml EX-101.CAL 35503
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ards-20190930_def.xml EX-101.DEF 197383
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ards-20190930_lab.xml EX-101.LAB 416592
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ards-20190930_pre.xml EX-101.PRE 341608
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38630 | Film No.: 191214414
SIC: 2834 Pharmaceutical Preparations